造影增強超音波市場：按模式、技術、應用和最終用戶分類 - 全球預測（2025-2032 年）

預計到 2032 年，造影增強超音波市場將成長至 36.9 億美元，複合年成長率為 6.65%。

造影增強超音波是一種具有臨床影響力的診斷方式，為重塑病患照護路徑和影像決策提供了一個簡潔的策略框架。

造影超音波代表了診斷影像領域的突破性進展，它將微氣泡造影造影與先進的超音波技術相結合，從而提高了病灶的可見性、血管評估和即時功能評估。過去十年間，臨床醫生擴大利用造影增強超音波來提高肝病學、腫瘤學、心臟病學和急診醫學的診斷準確性，同時影像團隊也在尋求能夠減少輻射暴露並簡化患者診療流程的方法。本文認為，造影超音波不僅是一種漸進式技術，更是一種正在重塑急診和門診診斷流程的實用臨床工具。

推動醫療保健領域全面採用並重塑採用方式的關鍵技術、臨床和商業性轉折點將影響技術的普及應用。

造影增強超音波領域正經歷多重變革，這些變革正在重塑臨床實踐、採購和創新重點。換能器設計、訊號處理和造影配方的進步提高了超音波在血管特性和病變評估方面的敏感度和特異性。同時，軟體分析和人工智慧驅動的影像增強技術的融合，正使影像解讀從完全依賴操作者轉向更標準化的評估，從而提高了不同機構和臨床醫生之間的可重複性。

不斷變化的關稅政策影響著造影超音波技術的供應鏈、採購決策和臨床應用趨勢。

近期貿易政策推出導致新關稅措施的實施，為採購負責人、生產經理和臨床營運團隊帶來了許多挑戰。影響進口零件、成品超音波系統和藥用級造影造影的關稅將推高下游成本，並可能導致資本投資放緩和籌資策略的重新評估。醫療系統和影像診斷中心目前不僅評估單位成本，還評估總擁有成本（TCO），包括維護、培訓以及在貿易環境變化下保障供應連續性所需的成本。

深度細分分析揭示了測試方法選擇、技術方案、臨床適應症和最終用戶特徵如何影響產品採納路徑和採購選擇。

細分洞察揭示了成像模式選擇、成像技術、臨床應用和最終用戶畫像如何共同決定應用模式和投資重點。模式選擇會影響操作流程；例如，多普勒成像可輔助血管評估和血流定量，諧波成像可增強組織對比度以檢測病變，而即時成像則支援床邊操作過程中的連續可視化。每種模式都有其獨特的訓練曲線和通訊協定要求，相關人員必須將其與臨床目標和人員配置模式相符。

區域採用趨勢和區域特定策略考量將決定臨床應用、報銷協調和供應鏈韌性。

區域趨勢表明，不同的應用促進因素、監管考慮和營運重點會影響造影超音波的廣泛應用。在美洲，醫保報銷機制、大型綜合醫療系統以及對照護現場影像的高度重視，持續推動急診和心臟科的臨床應用。對培訓計畫的投入以及集中式研究網路的存在，促進了區域證據的積累，並支持了整個醫療網路更廣泛的臨床接受度和通訊協定標準化。

主要企業正致力於整合硬體、造影劑最佳化、高階軟體分析和服務主導模式，以確保臨床應用。

造影超音波領域的企業正致力於多項相互融合的優先事項，以維持臨床相關性和商業性發展動能。產品研發投入主要集中在改善使用者人體工學設計、改進探頭技術以提高穿透力和解析度，以及整合先進的軟體工具以實現造影定量和灌注成像的自動化。這些措施旨在減少操作者差異，並創建可重複的指標，以便將其納入臨床決策演算法。

將臨床證據產生、產品易用性和供應鏈韌性相結合的可操作策略重點，將加速產品在醫療保健領域的持續應用。

產業領導者應推進一系列協調一致的努力，將臨床證據、商業化和供應鏈韌性相結合，以加速對比超音波造影技術的永續應用。應優先投資於多中心臨床研究，以產生可靠的比較療效證據，將對比造影超音波檢查與有意義的臨床終點和運作效率聯繫起來。更完善的證據基礎將有助於與支付方和臨床管治委員會進行建設性對話，從而在不斷變化的報銷限制下，使該技術得到更廣泛的認可。

我們採用嚴格的混合方法調查方法，結合臨床醫生訪談、監管審查、技術檢驗和證據三角驗證，以確保研究結果的可靠性。

本分析的調查方法結合了嚴謹的質性和量性方法，以確保研究結果既有實證依據，又與臨床實務密切相關。主要定性資料是透過對循環系統、放射學、腫瘤學和急診醫學領域的臨床醫生、醫院和影像中心的採購經理以及系統整合商和造影劑製造商的技術專家進行結構化訪談收集的。這些訪談深入剖析了影響實施決策的真實臨床工作流程、訓練需求和採購考量。

造影超音波超音波的臨床價值提案、操作前提條件和廣泛應用策略要求的綜合結論

造影超音波超音波正處於一個重要的轉折點，臨床效用、技術成熟度和實際操作條件在此交匯融合，為改善診斷服務創造了切實的機會。該技術的優勢——即時灌注成像、良好的安全性以及床邊應用性——使其成為心臟病學、腫瘤學、急診醫學以及更廣泛的診斷流程中的一種輔助工具。然而，要充分發揮其潛力，還需要在實證醫學證據累積、教育推廣和商業策略方面做出共同努力。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

• 將人工智慧驅動的血流分析整合到造影超音波中，以實現精確的腫瘤表徵
• 開發一種用於偏遠地區照護現場的攜帶式可攜式超音波造影
• 標靶微氣泡藥物的出現使得在分子影像和CEUS中早期檢測血管生物標記成為可能。
• 透過低劑量微氣泡通訊協定和安全檢驗，擴大造影超音波在兒科心臟病學的應用
• 將造影超音波與CT和MRI相結合的診斷影像技術取得了進展，可用於對肝臟疾病進行全面評估。
• 監管部門的核准和有利的報銷政策將加速造影超音波在亞洲和拉丁美洲等新興市場的應用。
• 奈米級超音波造影劑的創新可提高滲透性和深部病變的診斷準確性
• 整合造影超音波功能的遠端醫療平台發展迅速，可實現遠距第二意見和協作診斷。
• 臨床檢驗治療性超音波合併造影微氣泡在標靶藥物傳遞及超音波血栓溶解應用的療效
• 透過人工智慧驅動的自動異常檢測和標準化報告工作流程，提高造影超音波檢查的效率

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按模式造影增強超音波市場

• 多普勒成像
• 諧波成像
• 即時成像

第9章 按技術造影增強超音波市場

• 高機械指數成像
• 低機械指數成像

第10章 按應用分類的造影增強超音波市場

• 心臟病學
• 緊急醫療護理
• 腫瘤學
• 放射科

第11章 按最終用戶造影增強超音波市場

• 學術研究機構
• 門診手術中心
• 診斷影像中心
• 醫院

第12章 區域性造影增強超音波市場

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第13章造影增強超音波市場：依組別分類

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第14章 各國造影增強超音波市場

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第15章 競爭格局

• 2024年市佔率分析
• FPNV定位矩陣，2024
• 競爭分析
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Canon Medical Systems Corporation
  • Samsung Medison Co., Ltd.
  • Fujifilm Holdings Corporation
  • Bracco Imaging SpA
  • Lantheus Holdings, Inc.
  • Guerbet SA
  • Esaote SpA

The Contrast Enhanced Ultrasound Market is projected to grow by USD 3.69 billion at a CAGR of 6.65% by 2032.

A concise strategic framing of contrast enhanced ultrasound as a clinically impactful diagnostic modality reshaping patient pathways and imaging decision making

Contrast enhanced ultrasound represents a pivotal evolution in diagnostic imaging, combining microbubble contrast agents with advanced ultrasound modalities to enhance lesion conspicuity, vascular assessment, and real-time functional evaluation. Over the last decade, clinicians have increasingly leveraged contrast enhanced ultrasound to refine diagnostics in hepatology, oncology, cardiology, and emergency medicine, while imaging teams pursue modalities that reduce radiation exposure and streamline patient throughput. This introduction frames contrast enhanced ultrasound not merely as an incremental technology but as a practical clinical tool reshaping diagnostic pathways across acute and ambulatory settings.

The clinical appeal of contrast enhanced ultrasound stems from its safety profile, repeatability at the bedside, and the capacity to deliver dynamic perfusion information without ionizing radiation. Practitioners benefit from portable deployment and the immediacy of real-time imaging, enabling faster diagnostic decisions in emergency departments and procedural guidance in interventional suites. Concurrently, imaging departments and health systems have sought to integrate contrast protocols into standard workflows, balancing training needs with procedural efficiencies and reimbursement considerations.

As a strategic framing, this introduction emphasizes the interplay between clinical evidence generation, technology maturation, and stakeholder adoption. It sets the stage for deeper analysis of technological shifts, regulatory landscapes, procurement dynamics, and the commercial actions necessary to translate clinical potential into sustainable clinical practice.

Critical technological, clinical, and commercial inflection points that are driving widespread adoption and reshaping implementation approaches across care settings

The landscape for contrast enhanced ultrasound is undergoing several transformative shifts that recalibrate clinical practice, procurement, and innovation priorities. Advances in transducer design, signal processing, and contrast agent formulations are augmenting the sensitivity and specificity of ultrasound for vascular characterization and lesion assessment. Simultaneously, the integration of software analytics and AI-enabled image enhancement is transitioning interpretation from purely operator dependent to more standardized assessments, supporting reproducibility across institutions and clinicians.

Clinical protocols are evolving in parallel: cross-disciplinary guidelines increasingly recognize the role of contrast enhanced ultrasound in targeted applications, which fosters collaborative pathways between radiology, cardiology, oncology, and emergency medicine. This multidisciplinary adoption is encouraging clinical trials that expand indications and strengthen evidence for noninvasive diagnostic strategies. Additionally, point-of-care adoption is rising as emergency and critical care clinicians employ contrast techniques to expedite triage and therapeutic decisions, thereby reducing time to intervention in acute scenarios.

From a commercial standpoint, the market is witnessing consolidation of hardware and contrast agent strategies, with vendors focusing on platform differentiation through ease of use, automated workflows, and regulatory clarity. Supply chain resilience and strategic partnerships between imaging system manufacturers and contrast agent suppliers are becoming critical to ensure consistent clinical availability. These converging shifts underscore a rebalancing from technology novelty toward practical clinical integration and scalable adoption.

How evolving tariff policies are reshaping supply chains, procurement decisions, and clinical adoption dynamics for contrast enhanced ultrasound technologies

The imposition of new tariff measures originating from recent trade policy decisions has introduced a material consideration for procurement planners, manufacturing leaders, and clinical operations teams. Tariffs affecting imported components, finished ultrasound systems, and pharmaceutical-grade contrast agents create downstream cost pressures that can slow capital purchases and prompt reevaluation of sourcing strategies. Health systems and imaging centers are now assessing not only unit costs but also total cost of ownership, which includes maintenance, training, and supply continuity under altered trade conditions.

Operationally, providers are responding by diversifying supplier relationships, increasing inventory buffers for critical consumables, and exploring local assembly or regional distribution partnerships to mitigate tariff exposure. Some manufacturers are accelerating qualification of alternative suppliers and exploring relocation of key manufacturing steps to tariff-advantaged jurisdictions to preserve competitive pricing for end users. These shifts also influence clinical adoption timelines, as procurement committees may delay upgrades pending clearer tariff trajectories or seek financing arrangements to spread capital impact over multiple fiscal periods.

Clinically, the potential for higher per-procedure costs necessitates evidence that contrast enhanced ultrasound delivers measurable improvements in diagnostic accuracy, clinical throughput, or patient outcomes that offset incremental expense. Accordingly, groups responsible for clinical governance are intensifying comparative effectiveness studies and health economics analyses to justify continued adoption under the revised cost environment. The cumulative impact of tariff dynamics is therefore multi-dimensional, affecting supply chain architecture, capital planning, and the evidentiary case for procedure-level adoption.

Deep segmentation intelligence revealing how mode selection, technological approaches, clinical indications, and end user characteristics shape adoption pathways and procurement choices

Insight into segmentation reveals how modality choices, imaging technology, clinical applications, and end-user profiles collectively dictate adoption patterns and investment priorities. Mode selection influences operational workflows; for example, Doppler imaging techniques complement vascular assessments and flow quantification, while harmonic imaging enhances contrast-to-tissue separation for focal lesion detection, and real-time imaging supports continuous visualization during bedside procedures. Each mode presents distinct training curves and protocol requirements that stakeholders must reconcile with clinical objectives and staffing models.

Technology differentiation further shapes clinical utility and workflow efficiency. High mechanical index imaging enables targeted microbubble destruction and reperfusion assessment that can be advantageous for specific perfusion studies, whereas low mechanical index imaging supports continuous real-time contrast visualization without signal disruption, making it well suited for dynamic assessments in interventional settings. These technological choices affect equipment selection and protocol development, and they often drive vendor conversations around compatibility and software capabilities.

Application-driven priorities create clear use cases that appeal to different clinical stakeholders. Cardiology leverages contrast for enhanced endocardial border definition and myocardial perfusion assessment, while emergency medicine values rapid bedside diagnostic confirmation and trauma evaluation. Oncology benefits from tumor perfusion characterization to guide biopsy and monitor therapy response, and radiology integrates contrast enhanced ultrasound as a radiation-free adjunct for lesion characterization. End users vary in operational scale and clinical complexity; academic and research institutes emphasize protocol innovation and evidence generation, ambulatory surgical centers prioritize throughput and cost efficiency, diagnostic imaging centers focus on specialized workflows and outpatient access, and hospitals require integration across inpatient and outpatient services. Taken together, these segmentation perspectives inform product positioning, clinical engagement strategies, and training investments to maximize clinical relevance and operational feasibility.

Regional adoption dynamics and localized strategic considerations that determine clinical uptake, reimbursement alignment, and supply chain resilience across global territories

Regional dynamics present distinct adoption drivers, regulatory considerations, and operational priorities that influence the diffusion of contrast enhanced ultrasound. In the Americas, reimbursement structures, large integrated health systems, and a strong emphasis on point-of-care imaging continue to drive clinical uptake in emergency departments and cardiology services. Investment in training programs and the presence of centralized research networks foster local evidence generation, supporting broader clinical acceptance and protocol standardization across health networks.

Europe, Middle East & Africa comprise a heterogeneous landscape in which regulatory frameworks, public health priorities, and infrastructure variability result in differentiated adoption rates. Several European healthcare systems demonstrate robust integration of contrast enhanced ultrasound within hepatology and oncology pathways, while regions with constrained resources prioritize cost-effective modalities and streamlined training to expand diagnostic capacity. Cross-border collaborations and pan-regional clinical guidelines play a significant role in harmonizing practice and accelerating evidence dissemination across national boundaries.

The Asia-Pacific region is characterized by rapid capital investment in imaging infrastructure, strong private provider networks, and substantial growth in procedural volumes. Clinical demand is being driven by expanding oncology services and an increasing focus on minimally invasive diagnostics. Local manufacturing capabilities and regional supply chains also influence procurement strategies, making partnerships with regional distributors and localized service models particularly important for sustained adoption. Collectively, these regional insights highlight the need for tailored commercial approaches that align clinical evidence, reimbursement realities, and operational capabilities with local priorities.

How leading companies are converging on integrated hardware, contrast agent alignment, advanced software analytics, and service-driven models to secure clinical adoption

Companies operating in the contrast enhanced ultrasound space are focusing on several convergent priorities to sustain clinical relevance and commercial momentum. Product development investments center on enhancing user ergonomics, improving probe technology for better penetration and resolution, and integrating advanced software tools that automate contrast quantification and perfusion mapping. These capabilities aim to reduce operator variability and create reproducible metrics that can be incorporated into clinical decision algorithms.

Strategic partnerships between imaging system vendors and contrast agent developers are becoming increasingly important to ensure end-to-end compatibility and to streamline regulatory pathways. Firms are also augmenting their offerings with service models that include training curricula, accreditation support, and outcome-tracking tools to demonstrate clinical value to payers and health system purchasers. On the operational front, companies are optimizing supply chains by regionalizing distribution, qualifying multiple manufacturing partners, and offering flexible procurement arrangements such as subscription and pay-per-use models to lower the barrier to entry for cost-sensitive buyers.

Competitive differentiation is shifting from hardware features alone toward integrated solutions that combine imaging hardware, contrast agent consumables, software analytics, and clinical education. This integrated approach supports adoption by addressing clinical, operational, and financial decision criteria simultaneously, and positions companies to better respond to changing regulatory and tariff environments that affect global supply chains.

Actionable strategic priorities that align clinical evidence generation, product usability, and supply chain resilience to accelerate durable adoption across care settings

Industry leaders should pursue a coordinated set of actions that align clinical evidence, commercialization, and supply chain resilience to accelerate sustainable adoption of contrast enhanced ultrasound. Prioritize investment in multicenter clinical collaborations that generate robust comparative effectiveness evidence linking contrast enhanced ultrasound procedures to meaningful clinical endpoints and operational efficiencies. Strengthening the evidentiary base will support constructive engagements with payers and clinical governance committees, enabling broader procedural acceptance under evolving reimbursement constraints.

Simultaneously, accelerate integration of user-centric software and automated workflows that reduce operator dependency and lower training barriers. Embedding quantitative perfusion analytics and decision support directly into imaging platforms will improve reproducibility and create data assets that demonstrate value across care pathways. From a commercial and operational perspective, diversify supplier networks, regionalize critical component manufacturing, and develop flexible procurement offerings that reduce exposure to tariff volatility and capital constraints.

Finally, invest in scaled clinical education programs and credentialing pathways that equip a broader cohort of clinicians to perform contrast enhanced ultrasound safely and effectively. Partnerships with academic institutions and specialty societies can amplify adoption through guideline alignment and continuing education. By combining evidence generation, product usability enhancements, supply chain strategies, and education initiatives, industry leaders can create defensible adoption pathways that withstand policy shifts and competitive pressures.

A rigorous mixed-methods research approach integrating clinician interviews, regulatory review, technical validation, and evidence triangulation to ensure robust insights

The research methodology underpinning this analysis combined rigorous qualitative and quantitative approaches to ensure findings are evidence-based and practitioner-relevant. Primary qualitative inputs included structured interviews with clinicians across cardiology, radiology, oncology, and emergency medicine, procurement leaders in hospitals and imaging centers, and technical experts from system integrators and contrast agent manufacturers. These interviews provided rich insights into real-world workflows, training needs, and procurement considerations that shape deployment decisions.

Secondary research entailed systematic review of peer-reviewed clinical studies, regulatory guidance documents, professional society position statements, and technology white papers to triangulate clinical performance claims and safety profiles. Technical assessments of device capabilities and imaging modalities were corroborated with vendor product literature and independent bench testing reports. Data synthesis used a triangulation approach that reconciled clinician perspectives, regulatory context, and technical specifications to derive actionable insights while maintaining transparency about evidence sources and any limitations.

Quality assurance steps included cross-validation of interview findings with clinical trial outcomes, sensitivity checks for supply chain and tariff assumptions, and peer review by subject matter experts. Ethical considerations and patient safety factors were integrated throughout the methodology, ensuring that recommendations prioritize clinical benefit and operational viability.

Consolidated conclusions on the clinical value proposition, operational prerequisites, and strategic imperatives for broader adoption of contrast enhanced ultrasound

Contrast enhanced ultrasound stands at a pragmatic inflection point where clinical utility, technological maturity, and operational realities converge to create tangible opportunities for improved diagnostic care. The modality's strengths-real-time perfusion imaging, favorable safety profile, and bedside applicability-position it as a complementary tool across cardiology, oncology, emergency medicine, and broader diagnostic workflows. However, realizing its full potential requires aligned efforts across evidence generation, education, and commercial strategy.

Operationally, stakeholders must navigate policy shifts and supply chain complexities that influence procurement timelines and capital investment decisions. Clinical teams and manufacturers that collaborate on standardized protocols, reproducible quantitative measures, and accessible training pathways will be best positioned to accelerate adoption. Companies that integrate hardware, consumables, and analytics into cohesive solutions and that mitigate supply chain risk will create stronger value propositions for health systems and outpatient providers.

In conclusion, contrast enhanced ultrasound offers a clinically meaningful, low-risk imaging option that can improve diagnostic confidence and patient management when deployed with thoughtful evidence, training, and procurement strategies. The path forward is collaborative and requires sustained commitment to demonstrating clinical impact and operational feasibility.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of AI-driven perfusion analysis in contrast enhanced ultrasound for precise tumor characterization
• 5.2. Development of handheld and portable contrast enhanced ultrasound systems for point of care diagnostics in remote settings
• 5.3. Emergence of targeted microbubble agents enabling molecular imaging and early detection of vascular biomarkers in CEUS
• 5.4. Expansion of contrast enhanced ultrasound applications in pediatric cardiology with low-dose microbubble protocols and safety validation
• 5.5. Advancements in fusion imaging combining contrast enhanced ultrasound with CT and MRI for comprehensive lesion evaluation in liver disease
• 5.6. Regulatory approvals and favorable reimbursement policies accelerating adoption of contrast enhanced ultrasound in emerging markets across Asia and Latin America
• 5.7. Innovations in nano-sized ultrasound contrast agents for improved tissue penetration and enhanced diagnostic accuracy in deep-seated lesions
• 5.8. Growth of telemedicine platforms integrating contrast enhanced ultrasound capabilities for remote second opinions and collaborative diagnostics
• 5.9. Clinical validation of therapeutic ultrasound combined with contrast microbubbles for targeted drug delivery and sonothrombolysis applications
• 5.10. AI-powered automated anomaly detection and standardized reporting workflows transforming the efficiency of contrast enhanced ultrasound exams

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Contrast Enhanced Ultrasound Market, by Mode

• 8.1. Doppler Imaging
• 8.2. Harmonic Imaging
• 8.3. Real Time Imaging

9. Contrast Enhanced Ultrasound Market, by Technology

• 9.1. High Mechanical Index Imaging
• 9.2. Low Mechanical Index Imaging

10. Contrast Enhanced Ultrasound Market, by Application

• 10.1. Cardiology
• 10.2. Emergency Medicine
• 10.3. Oncology
• 10.4. Radiology

11. Contrast Enhanced Ultrasound Market, by End User

• 11.1. Academic And Research Institutes
• 11.2. Ambulatory Surgical Centers
• 11.3. Diagnostic Imaging Centers
• 11.4. Hospitals

12. Contrast Enhanced Ultrasound Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Contrast Enhanced Ultrasound Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Contrast Enhanced Ultrasound Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. GE HealthCare Technologies Inc.
  • 15.3.2. Koninklijke Philips N.V.
  • 15.3.3. Siemens Healthineers AG
  • 15.3.4. Canon Medical Systems Corporation
  • 15.3.5. Samsung Medison Co., Ltd.
  • 15.3.6. Fujifilm Holdings Corporation
  • 15.3.7. Bracco Imaging S.p.A.
  • 15.3.8. Lantheus Holdings, Inc.
  • 15.3.9. Guerbet S.A.
  • 15.3.10. Esaote S.p.A.

LIST OF FIGURES

• FIGURE 1. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. CONTRAST ENHANCED ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. CONTRAST ENHANCED ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. CONTRAST ENHANCED ULTRASOUND MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DOPPLER IMAGING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DOPPLER IMAGING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DOPPLER IMAGING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DOPPLER IMAGING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DOPPLER IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DOPPLER IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HARMONIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REAL TIME IMAGING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REAL TIME IMAGING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REAL TIME IMAGING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REAL TIME IMAGING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REAL TIME IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REAL TIME IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HIGH MECHANICAL INDEX IMAGING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HIGH MECHANICAL INDEX IMAGING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HIGH MECHANICAL INDEX IMAGING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HIGH MECHANICAL INDEX IMAGING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HIGH MECHANICAL INDEX IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HIGH MECHANICAL INDEX IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LOW MECHANICAL INDEX IMAGING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LOW MECHANICAL INDEX IMAGING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LOW MECHANICAL INDEX IMAGING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LOW MECHANICAL INDEX IMAGING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LOW MECHANICAL INDEX IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY LOW MECHANICAL INDEX IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY EMERGENCY MEDICINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY EMERGENCY MEDICINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY EMERGENCY MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY EMERGENCY MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY EMERGENCY MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY EMERGENCY MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RADIOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RADIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 94. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 95. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 96. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 97. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 98. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 99. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 100. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 101. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 102. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 103. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 104. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 105. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 106. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 107. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 108. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 109. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 110. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 111. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 112. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 113. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 116. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 117. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 118. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 119. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 120. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 121. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 122. LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 133. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 136. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 137. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 138. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 139. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 140. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 141. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 142. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 143. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 144. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 145. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 146. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 147. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 148. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 149. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 150. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 151. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 152. MIDDLE EAST CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 153. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 156. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 157. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 158. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 159. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 160. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 161. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 162. AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 163. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 164. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 165. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 166. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 167. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 168. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 169. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 170. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 171. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 172. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 175. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 176. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 177. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 178. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 179. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 180. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 181. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 182. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 183. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 184. ASEAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 185. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 186. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 187. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 188. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 189. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 190. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 191. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 192. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 193. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 194. GCC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 195. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 196. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 197. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 198. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 199. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 200. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 201. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 202. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 203. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 204. EUROPEAN UNION CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 205. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 208. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 209. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 210. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 211. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 212. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 213. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 214. BRICS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 215. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 216. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 217. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 218. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 219. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 220. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 221. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 222. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 223. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 224. G7 CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 225. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 226. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 227. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 228. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 229. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 230. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 231. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 232. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 233. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 234. NATO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 237. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 238. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 239. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 240. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 241. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 242. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 243. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 244. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 245. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 246. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 247. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 248. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 249. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 250. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 251. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 252. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 253. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 254. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 255. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 256. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 257. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 258. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 259. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 260. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 261. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 262. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 263. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 264. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 265. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 266. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 267. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 268. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 269. UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 270. UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 271. UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 272. UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 273. UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 274. UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 275. UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 276. UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 277. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 278. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 279. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 280. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 281. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 282. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 283. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 284. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 285. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 286. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 287. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 288. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 289. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 290. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 291. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 292. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 293. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 294. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 295. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 296. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 297. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 298. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 299. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 300. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 301. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 302. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 303. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 304. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 305. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 306. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 307. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 308. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 309. SPAIN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
• TABLE 310. SPAIN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
• TABLE 311. SPAIN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 312. SPAIN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 313. SPAIN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 314. SPAIN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 315. SPAIN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 316. SPAIN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 317. CHINA CONTRAST